Market Indices
Latest News
 |
| ||
| ||
| ||
|
Price Targets
Wei Xiong from UBS issued a price target of $13.00 for TME on 2026-03-18 15:52:00.The adjusted price target was set to $13.00.At the time of the announcement, TME...
March 18, 2026 TME -1.06%
Ellie Jiang from Macquarie issued a price target of $10.70 for TME on 2026-03-17 18:46:00.The adjusted price target was set to $10.70.At the time of the announcement, TME...
March 17, 2026 TME -1.06%
Greg Renza from Truist Financial issued a price target of $8.00 for BCYC on 2026-03-17 15:51:00.The adjusted price target was set to $8.00.At the time of the announcement,
March 17, 2026 BCYC -0.20%
Market Movers
| Top Gainers (%) | |||||||||||||||||||
| TRIB Trinity Biotech plc | 0.70
15.46% | ||||||||||||||||||
| CLGN CollPlant Biotechnologies | 0.39
13.86% | ||||||||||||||||||
| NCNA NuCana plc | 2.10
10.53% | ||||||||||||||||||
| BWAY BrainsWay Ltd. | 14.30
8.09% | ||||||||||||||||||
| ADXN Addex Therapeutics Ltd | 6.99
7.87% | ||||||||||||||||||
| AMBO Ambow Education Holding L | 2.28
6.54% | ||||||||||||||||||
| CIG-C Companhia Energética de | 3.83
6.52% | ||||||||||||||||||
| ZEPP Zepp Health Corporation | 12.20
5.90% | ||||||||||||||||||
Annual/Quarterly Reports Summary
Summit Therapeutics Inc. (SMMT) Quarterly Report: What Does It Reveal About Their Sector Performance
May 1, 2025 SMMT 2.66%
In a landscape of rising revenues and increasing operational costs, the company navigates challenges with a focus on innovation and sustainability. Despite a dip in net income and profit declines...
February 5, 2025 TEVA 1.44%
In a year marked by resilience, the company celebrated record revenues of $25 billion, driven by strong ticket sales and operational efficiency. With a focus on North America, it reduced...
January 27, 2025 CUK -0.32%